BlackRock Health Sciences Trust (BME)
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Industry: Asset Management
BlackRock Health Sciences Trust
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 12.92M shares outstanding
USBlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC.
It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Leadership
Aaron Wasserman
Chief Compliance Officer (“CCO”)
Janey Ahn
Secretary
Jay M. Fife
Treasurer
John M. Perlowski
Director/ Trustee, President and Chief Executive Officer
Employees
--
Country
US
Sector
Financial Services
Website
blackrock.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Liu Xiang | -- | Option Exercise | 389.104 | -- | Jan 30, 2026 |
| Liu Xiang | -- | Withholding/Transfer | 389.104 | $16.3K | Jan 30, 2026 |
 Xie H Erin | -- | Option Exercise | 11.4K | -- | Jan 30, 2026 |
| Xie H Erin | -- | Withholding/Transfer | 11.4K | $479.4K | Jan 30, 2026 |
| Liu Xiang | -- | Grant/Award | 372.964 | $15.6K | Jan 30, 2026 |
| Liu Xiang | -- | Option Exercise | 202.603 | -- | Jan 30, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
MORGAN STANLEY | 364.7K | 2.8% | 13F |
BANK OF AMERICA CORP /DE/ | 275.4K | 2.1% | 13F |
1607 Capital Partners, LLC | 163.6K | 1.3% | 13F |
WELLS FARGO & COMPANY/MN | 159.8K | 1.2% | 13F |
ROYAL BANK OF CANADA | 154.9K | 1.2% | 13F |
Nova R Wealth, Inc. | 140.9K | 1.1% | 13F |
Karpus Management, Inc. | 140.3K | 1.1% | 13F |
Invesco Ltd. | 130.1K | 1.0% | 13F |
LPL Financial LLC | 113.1K | 0.9% | 13F |
RAYMOND JAMES FINANCIAL INC | 109.8K | 0.8% | 13F |
based on 12.92M shares outstanding
US30d Avg
41.05K
60d Avg
39.59K
90d Avg
42.41K